Show simple item record

dc.contributor.authorSvingen, Marit
dc.identifier.citationJournal of Responsible Innovation. 2022, .en_US
dc.description.abstractGene editing technologies like CRISPR have raised questions about the need for new regulations throughout Europe. In Norway, the Norwegian Biotechnology Advisory Board initiated a comprehensive process to formulate a proposal for a relaxation of the regulation of GMOs in 2016. This article investigates the Board's initiative as part of the prevailing RRI policy discourse and follows how the process unfolded as a public engagement exercise. A document analysis of the Board's statements and the public's written comments revealed that the Board managed to construct a nuanced public debate around GMOs; however, the Board did not acknowledge that the different interpretations of key terms in the proposal led to very different conclusions as to how CRISPR should be regulated. Therefore, the inclusion of the public appears more as a means to build support for the proposal than as a learning exercise as understood by the RRI-framework.en_US
dc.publisherTaylor & Francisen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.titlePaving the way for a softer regulation of CRISPR in Norway: public engagement as window dressingen_US
dc.title.alternativePaving the way for a softer regulation of CRISPR in Norway: public engagement as window dressingen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.source.journalJournal of Responsible Innovationen_US

Files in this item


This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal